A 501(c)(3) nonprofit organization solely run by volunteers. EIN: 82-2331553

Funding DIPG clinical trial

Funding DIPG clinical trial

Sat, 04/06/2019 - 02:32

DIPG Research funding from federal government is less than 1% of the total cancer funding. In the last few years most of the funding for DIPG research has been provided by philanthropic organizations like ours. Here is our part, thanks to all of you.

December 29, 2019

Today, on what would have been Mithil’s 16th birthday we have donated $105k to DIPG research!! None of this would have been possible without all of your continued support. From all of us at the Mithil Prasad Foundation, thank you so much! Happy 16th birthday Mithi!!

Research Fund 2019

December 29, 2018

We had done numerous trips to UCSF when Mithil was sick with the hope that he will get better. It was a very surreal moment when, this time in December 2018 we went to UCSF to hand over a check to support DIPG research! This time to advance the findings about DIPG through clinical trials. Thanks to all our supporters who made this possible. 

Our foundation has provided funds for a clinical trial - H3.3K27M specific peptide vaccine combined with poly-ICLC for the treatment of newly diagnosed HLA-A2+ H3.3K27M positive diffuse intrinsic pontine glioma (DIPG) as well as other newly diagnosed HLA-A2+ H3.3K27M-positive gliomas. For more details go to http://www.pnoc.us/clinical-trials/h33k27m-specific-peptide-vaccine-combined-poly-iclc-treatment-newly-diagnosed-hla-a2 

UCSF Research

 

Tags